Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Craig Jordan

Showing results (151-160 of 218) with videos related to

Pageof 22
Sort By:
International Journal of Oncology|January 5, 2007
Role for HER2/neu and HER3 in fulvestrant-resistant breast cancerClodia Osipo, Kathleen Meeke, Dong Cheng, et al.
Molecular Pharmacology|July 9, 2011
The selective estrogen receptor modulator bazedoxifene inhibits hormone-independent breast cancer cell growth and down-regulates estrogen receptor α and cyclin D1Joan S Lewis-Wambi, Helen Kim, Ramona Curpan, et al.
Breast (Edinburgh, Scotland)|October 22, 2011
The St. Gallen Prize Lecture 2011: evolution of long-term adjuvant anti-hormone therapy: consequences and opportunitiesV Craig Jordan, Ifeyinwa Obiorah, Ping Fan, et al.
Journal of Medicinal Chemistry|March 26, 2010
Structure-function relationships of estrogenic triphenylethylenes related to endoxifen and 4-hydroxytamoxifenPhilipp Y Maximov, Cynthia B Myers, Ramona F Curpan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2008
Aspirin sensitizes cancer cells to TRAIL-induced apoptosis by reducing survivin levelsMeiling Lu, Anne Strohecker, Feng Chen, et al.
European Journal of Cancer (Oxford, England : 1990)|July 11, 2008
Overexpression of CEACAM6 promotes migration and invasion of oestrogen-deprived breast cancer cellsJoan S Lewis-Wambi, Heather E Cunliffe, Helen R Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 19, 2019
Tamoxifen Metabolism and Breast Cancer Recurrence: A Question Unanswered by CYPTAMMatthew P Goetz, Vera J Suman, Yusuke Nakamura, et al.
Endocrine-Related Cancer|November 23, 2017
A unifying biology of sex steroid-induced apoptosis in prostate and breast cancersPhilipp Y Maximov, Balkees Abderrahman, Ramona F Curpan, et al.
Cancer Letters|October 31, 2002
Role of the progesterone receptor (PR) in susceptibility of mouse mammary gland to 7,12-dimethylbenz[a]anthracene-induced hormone-independent preneoplastic lesions in vitroRobert T Chatterton, John P Lydon, Rajendra G Mehta, et al.
International Journal of Oncology|July 13, 2005
Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complexBin Chen, Csaba Gajdos, Rita Dardes, et al.
Pageof 22

Showing results (151-160 of 218) with videos related to

Sort By:
Pageof 22
International Journal of Oncology|January 5, 2007
Role for HER2/neu and HER3 in fulvestrant-resistant breast cancerClodia Osipo, Kathleen Meeke, Dong Cheng, et al.
Molecular Pharmacology|July 9, 2011
The selective estrogen receptor modulator bazedoxifene inhibits hormone-independent breast cancer cell growth and down-regulates estrogen receptor α and cyclin D1Joan S Lewis-Wambi, Helen Kim, Ramona Curpan, et al.
Breast (Edinburgh, Scotland)|October 22, 2011
The St. Gallen Prize Lecture 2011: evolution of long-term adjuvant anti-hormone therapy: consequences and opportunitiesV Craig Jordan, Ifeyinwa Obiorah, Ping Fan, et al.
Journal of Medicinal Chemistry|March 26, 2010
Structure-function relationships of estrogenic triphenylethylenes related to endoxifen and 4-hydroxytamoxifenPhilipp Y Maximov, Cynthia B Myers, Ramona F Curpan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2008
Aspirin sensitizes cancer cells to TRAIL-induced apoptosis by reducing survivin levelsMeiling Lu, Anne Strohecker, Feng Chen, et al.
European Journal of Cancer (Oxford, England : 1990)|July 11, 2008
Overexpression of CEACAM6 promotes migration and invasion of oestrogen-deprived breast cancer cellsJoan S Lewis-Wambi, Heather E Cunliffe, Helen R Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 19, 2019
Tamoxifen Metabolism and Breast Cancer Recurrence: A Question Unanswered by CYPTAMMatthew P Goetz, Vera J Suman, Yusuke Nakamura, et al.
Endocrine-Related Cancer|November 23, 2017
A unifying biology of sex steroid-induced apoptosis in prostate and breast cancersPhilipp Y Maximov, Balkees Abderrahman, Ramona F Curpan, et al.
Cancer Letters|October 31, 2002
Role of the progesterone receptor (PR) in susceptibility of mouse mammary gland to 7,12-dimethylbenz[a]anthracene-induced hormone-independent preneoplastic lesions in vitroRobert T Chatterton, John P Lydon, Rajendra G Mehta, et al.
International Journal of Oncology|July 13, 2005
Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complexBin Chen, Csaba Gajdos, Rita Dardes, et al.
Pageof 22